Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prolonged decrease of serum calcium concentration by murine gamma-interferon in hypercalcemic, human tumor

K Sato1, T Satoh, K Shizume

  • 1Department of Medicine, Tokyo Women's Medical College, Japan.

Cancer Research
|January 15, 1992
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pebbles and sand on asteroid (162173) Ryugu: In situ observation and particles returned to Earth.

Science (New York, N.Y.)·2022
Same author

The geomorphology, color, and thermal properties of Ryugu: Implications for parent-body processes.

Science (New York, N.Y.)·2019
Same author

The rubble-pile asteroid Itokawa as observed by Hayabusa.

Science (New York, N.Y.)·2006
Same author

Detailed images of asteroid 25143 Itokawa from Hayabusa.

Science (New York, N.Y.)·2006
Same author

Interaction between leptin and growth hormone (GH)/IGF-I axis.

Endocrine journal·2002
Same author

Distribution of c-fos mRNA in the brain following intracerebroventricular injection of nitric oxide (NO)-releasing compounds: possible role of NO in central cardiovascular regulation.

Journal of neuroendocrinology·2000

Murine gamma-interferon (MuIFN-gamma) effectively reduces high blood calcium in mice with tumors by inhibiting osteoclast activity. This cytokine offers a sustained effect, unlike calcitonin, suggesting potential for treating malignancy-associated hypercalcemia.

Area of Science:

  • Immunology
  • Endocrinology
  • Oncology

Background:

  • Humoral hypercalcemia of malignancy is a serious complication.
  • Interleukin 1 and parathyroid hormone-related protein contribute to hypercalcemia.
  • Murine gamma-interferon (MuIFN-gamma) inhibits bone resorption in vitro.

Purpose of the Study:

  • To evaluate the in vivo efficacy of MuIFN-gamma in treating hypercalcemia.
  • To investigate the mechanism of action of MuIFN-gamma on bone resorption.

Main Methods:

  • MuIFN-gamma was administered subcutaneously to hypercalcemic, tumor-bearing nude mice.
  • Serum calcium levels, urinary calcium excretion, and osteoclast numbers were analyzed.
  • In vitro osteoclast formation assays were performed.

Related Experiment Videos

Main Results:

  • MuIFN-gamma dose-dependently reduced serum calcium levels in tumor-bearing mice.
  • The effect of MuIFN-gamma was prolonged (>7 days) and superior to calcitonin.
  • MuIFN-gamma decreased osteoclast formation and bone resorption, reducing serum calcium and urinary calcium.

Conclusions:

  • MuIFN-gamma effectively suppresses osteoclast formation and bone resorption in vivo.
  • MuIFN-gamma ameliorates humoral hypercalcemia without an escape phenomenon.
  • MuIFN-gamma is a potential therapeutic agent for malignancy-associated hypercalcemia.